Our History
Leila Cupersmith, Founder & CEO of Choice ClinOps, brings more than 20 years of experience leading complex global oncology and rare disease clinical trials from concept through closeout. Throughout her career, she saw the same avoidable challenges derail studies—millions of dollars wasted, preventable delays, misaligned resources, fractured sponsor–CRO–site relationships, misaligned stakeholders, and poor vendor or site selection and management. On the programs she led, she built and executed strategies that consistently turned these problems around, delivering earlier milestones, stronger collaboration, and millions of dollars in cost savings.
Choice ClinOps was founded to bring these proven strategies to a greater number of small and mid-size sponsors who too often lack access to the same level of operational excellence as large pharma. Our model is intentionally nimble, embedded, attentive, and customer-focused, designed to fit into a small to mid-size sponsor’s existing structure as a seamless extension of the team.
Although Leila leads the company, Choice ClinOps is not a solo consultancy. We are a solid fractional team of seasoned clinical operations professionals, each with 20+ years of hands-on cancer or rare disease trial experience across sponsors, CROs, and sites. Our experience has included delivering clinical trials throughout over 80 countries. This collective expertise means sponsors benefit from leaders who have sat in every seat at the table and learned by actually doing the work themselves—able to anticipate cancer and rare disease clinical trial operations challenges, navigate complexity, and execute studies with precision.
For small to mid-size sponsors running global cancer and rare disease clinical trials, Choice ClinOps offers the right blend of experience, agility, and partnership to deliver high-quality studies—without the waste, delays, or rigidity of traditional models.
👉 Connect with Leila on LinkedIn: https://www.linkedin.com/in/Leila-Cupersmith/
Who We Are at Choice ClinOps: Cancer and Rare Disease Clinical Trial Operations Solutions - Fractional and Consulting
Our Mission
At Choice ClinOps, we believe every patient globally deserves access to top-quality, equitable, safe, well-run clinical trials — and every clinical trial sponsor, CRO and site network deserves an operations partner who leads with expertise, ethics, and empathy.
Our mission is to empower global small to mid-size cancer and rare disease sponsors, CROs, and site networks to deliver global clinical trials that are faster, smarter, cost- and time-efficient, and truly human-centered. We do this by embedding senior clinical trial operations experts who bring decades of hands-on global clinical trial operations experience at Sponsors, CROs, and site networks. We pride ourselves on successfully and intentionally uniting sponsors, CROs, sites, vendors, patients, and caregivers into one cohesive, purpose-driven team.
We exist to make complex cancer and rare disease clinical trials feel clear, connected, and achievable - with the lowest possible sponsor budgetary spend — so that life-changing therapies reach patients who need them most with the safety, speed, and quality the patients deserve - and sponsors can filter saved money toward developing other therapeutics.
Our Values
At Choice ClinOps: Cancer and Rare Disease Clinical Trial Operations Solutions - Fractional and Consulting, we believe in integrity, excellence, and collaboration (no silos). We have a history of and are dedicated to building strong relationships with our clients and delivering exceptional service that exceeds their expectations. High standards, ethics, patients and caregivers are weaved into every decision and action made at Choice ClinOps.